drugset / Trial / NCT00395486
ROMEO (Rosuvastatin in Metabolic syndrOme)
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to compare the effect of rosuvastatin 10mg with atorvastatin 10mg after 6 weeks of treatment in the ratio of ApoB/ApoA1 in subjects with metabolic syndrome.
Timeline
- Start
- 2006-09
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 10 mg | — |